PE
AGL icon

Point72 Europe’s Agilon Health AGL Stock Holding History

Point72 Europe’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.06K Buy
+313
New +$11.8K ﹤0.01% 557

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Europe's AGL Position: Q3 2025 in Review

Point72 Europe opened a new position in Agilon Health (AGL) in Q3 2025: 313 shares worth $8.06K. The stake represents ﹤0.01% of the portfolio and ranks #557 among its holdings.

190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Point72 Europe held 313 shares of Agilon Health worth $8.06K as of Q3 2025.
  • Agilon Health was a new Point72 Europe position in Q3 2025.
  • Agilon Health made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #557 holding.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.